Cargando…
Effect of Patent Expiry on the Performance of Innovator Multinational Pharmaceutical Companies in a Low Middle Income Country
Patent expiry or loss of exclusivity exposes innovator pharmaceutical companies to changes in the market dynamics brought about by increased production of generics by rival companies after patent expiration. This current study focused on the effect of generic products manufacturing and competitive m...
Autores principales: | Khalil, Farrukh, Onyango, Joseph Odhiambo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014174/ https://www.ncbi.nlm.nih.gov/pubmed/35445207 http://dx.doi.org/10.3389/fmedt.2022.783460 |
Ejemplares similares
-
Pharmaceutical Innovations: The Grand Challenges Ahead
por: Aroeira, Rita I., et al.
Publicado: (2020) -
Low-cost locally manufacturable unilateral imperial external fixator for low- and middle-income countries
por: Saeidi, Mehdi, et al.
Publicado: (2022) -
Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011) -
The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review
por: Vondeling, Gerard T., et al.
Publicado: (2018) -
The impact of patent expiry on drug prices: insights from the Dutch market
por: van der Schans, Simon, et al.
Publicado: (2020)